Gene · 6470
Papers1,819
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,819
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SHMT as a Potential Therapeutic Target for Renal Cell Carcinoma. | Front Biosci (Landmark Ed) | 2023 | 37796681 | PubTator, text mining | PubMed |
| Oxalate (dys)Metabolism: Person-to-Person Variability, Kidney and Cardiometabolic Toxicity. | Genes (Basel) | 2023 | 37761859 | PubTator, text mining | PubMed |
| HOXD8 suppresses renal cell carcinoma growth by upregulating SHMT1 expression. | Cancer Sci | 2023 | 37752684 | PubTator, text mining | PubMed |
| Exploration of potential novel drug targets and biomarkers for small cell lung cancer by plasma proteome screening. | Front Pharmacol | 2023 | 37745050 | PubTator, text mining | PubMed |
| Preventive effects of 13 different drugs on colorectal cancer: a network meta-analysis. | Arch Med Sci | 2023 | 37732038 | PubTator, text mining | PubMed |
| Sulforaphane rewires central metabolism to support antioxidant response and achieve glucose homeostasis. | Redox Biol | 2023 | 37703668 | PubTator, text mining | PubMed |
| The Dipeptide Gly-Pro (GP), Derived from Hibiscus sabdariffa, Exhibits Potent Antifibrotic Effects by Regulating the TGF-β1-ATF4-Serine/Glycine Biosynthesis Pathway. | Int J Mol Sci | 2023 | 37686422 | PubTator, text mining | PubMed |
| Integrated Metabolome and Transcriptome Analyses Reveal Amino Acid Biosynthesis Mechanisms during the Physiological Maturity of Grains in Yunnan Hulled Wheat (Triticum aestivum ssp. yunnanense King). | Int J Mol Sci | 2023 | 37686281 | PubTator, text mining | PubMed |
| MiRNAs in Lung Adenocarcinoma: Role, Diagnosis, Prognosis, and Therapy. | Int J Mol Sci | 2023 | 37686110 | PubTator, text mining | PubMed |
| Arginine, Transsulfuration, and Folic Acid Pathway Metabolomics in Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. | Cells | 2023 | 37681911 | PubTator, text mining | PubMed |
| Metabolic reprogramming of three major nutrients in platinum-resistant ovarian cancer. | Front Oncol | 2023 | 37681030 | PubTator, text mining | PubMed |
| Serine-associated one-carbon metabolic reprogramming: a new anti-cancer therapeutic strategy. | Front Oncol | 2023 | 37664062 | PubTator, text mining | PubMed |
| Aminooxy acetic acid suppresses Th17-mediated psoriasis-like skin inflammation by inhibiting serine metabolism. | Front Pharmacol | 2023 | 37649889 | PubTator, text mining | PubMed |
| Typing and modeling of hepatocellular carcinoma based on disulfidptosis-related amino acid metabolism genes for predicting prognosis and guiding individualized treatment. | Front Oncol | 2023 | 37637055 | PubTator, text mining | PubMed |
| Artificial Intelligence Frameworks to Detect and Investigate the Pathophysiology of Spaceflight Associated Neuro-Ocular Syndrome (SANS). | Brain Sci | 2023 | 37626504 | PubTator, text mining | PubMed |
| Hyperhomocysteinemia and Accelerated Aging: The Pathogenic Role of Increased Homocysteine in Atherosclerosis, Osteoporosis, and Neurodegeneration. | Cureus | 2023 | 37605676 | PubTator, text mining | PubMed |
| One-carbon metabolizing enzyme ALDH1L1 influences mitochondrial metabolism through 5-aminoimidazole-4-carboxamide ribonucleotide accumulation and serine depletion, contributing to tumor suppression. | Sci Rep | 2023 | 37596270 | PubTator, text mining | PubMed |
| Structure-Based Design of Transport-Specific Multitargeted One-Carbon Metabolism Inhibitors in Cytosol and Mitochondria. | J Med Chem | 2023 | 37582241 | PubTator, text mining | PubMed |
| Co-inhibition of glutaminolysis and one-carbon metabolism promotes ROS accumulation leading to enhancement of chemotherapeutic efficacy in anaplastic thyroid cancer. | Cell Death Dis | 2023 | 37573361 | PubTator, text mining | PubMed |
| Mangiferin is a new potential antimalarial and anticancer drug for targeting serine hydroxymethyltransferase. | Arch Biochem Biophys | 2023 | 37543353 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6470/papers?page=8